![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 25, 2006 4:12:58 AM
Mr. Gabriel also gave insights into the revenue potential for DNA research and an update on the development of compounds to treat various diseases. He elaborated on the revenue potential for the Company's relationships with Biofrontera of Germany, in which the company has a significant ownership stake, as well as the continuing relationship with Harvard University's Beth Israel Deaconess Hospital and the new relationship with Emory University's Center for Medical Genomics.
The interview is available for streaming by going to http://www.wallstreetreporter.com/profile.php?id=19412. Free registration is required to enter the site. The interview will be available in the site's archive until November 15, 2006.
ANN
FEATURED Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • Sep 9, 2024 9:34 AM
North Bay Resources Commences Gold Shipments, Fran Gold Project, British Columbia; Enters Taber Gold Mine JV, Sierra County, California • NBRI • Sep 9, 2024 9:15 AM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM